Variant Perception

Figures converted from AUD at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Where We Disagree With the Market

The sell-side cluster around $15.68 is anchored to a non-IFRS earnings base, a closeable margin gap, and an unconditional master-franchise agreement — and the evidence partially refutes all three. Four of five published brokers (UBS, Jefferies, Barrenjoey, Morningstar) target $15.68 against the $12.02 spot, only Citi sits at $14.15 Sell, and the implicit consensus is "wait for the H1-style margin inflection to compound." Our read is that the H1 FY26 +160bps margin print delivered +1.0% underlying EBIT growth on a 312-store closure tailwind — that is mix arithmetic, not operating leverage — and the structural questions on hand (whether "underlying" earnings are a forecastable base, whether the 760bps EBITDA-margin gap to DOM is structural, whether the parent will keep tolerating DPE-specific underperformance) cannot be resolved by the 26 August 2026 FY26 print that the market is treating as the binary trigger. The properly-priced range sits closer to Citi's $14.15 or below — not because we are bearish on pizza, but because three of the assumptions doing the work in the $15.68 cluster are observable and currently fail their tests.

Variant Perception Scorecard

The 62 variant-strength reflects three real disagreements with disciplined resolution paths, balanced against a sell-side that has already begun bifurcating (Citi Sell on one side; $15.68 cluster on the other) — i.e., the variant is meaningful but not a clean asymmetry against a unanimous consensus. Consensus clarity is high because every broker base case can be traced to "underlying EBITDA recovery to $200M+ at 11-13x EV/EBITDA," which is a single, testable underwriting frame. Evidence strength is the binding constraint: 5-of-5 years of "significant items," 760bps margin gap on identical platform, and DPZ Q4 2025 framing of DPE as the "single international laggard" are concrete data points, but each is still one print from being overturned. First resolution arrives August 2026 (FY26 result), with the durable read in February 2027 (H1 FY27 — first full half under Gregory).

Consensus Map

The consensus is unusually testable here because each anchor (underlying EBITDA, margin convergence, MFA permanence, Cowin discount) maps to an observable signal that hits the tape inside the next 9 months. That makes the variant exercise concrete: we are not arguing that the market "feels too bullish" — we are arguing that three specific underwriting assumptions cannot all survive the FY26 result and the DPZ Q2-Q3 2026 calls.

The Disagreement Ledger

Disagreement 1 — "Underlying" is the management measure, not the right base. A consensus analyst at $15.68 would say: "The FY25 $106M of significant items was a kitchen-sink CEO-transition cleanup; FY26 underlying EBITDA recovers to $200M+ at 11-13x = $15.68+." The evidence disagrees: significant items appeared in 5 of 5 years and the litigation matters inside the bucket (Speed Rabbit, Fast Food Industry Award class action, Pizza Sprint) recur by definition. If FY26 prints another $21-36M of "non-recurring" charges, the market would have to concede that the audited statutory result — not the management bridge — is the appropriate base, and the multiple would re-rate against an EBITDA closer to $129-150M rather than $200M. The cleanest disconfirming signal is a FY26 result with significant items <$14M pre-tax AND an Audit and Risk Committee statement that the underlying reconciliation has been reviewed (rather than just the statutory statements).

Disagreement 2 — The DOM-margin gap is structural, not executable. A consensus analyst would say: "Same brand, same MFA, same Pulse POS, same Dolly ordering platform — the platform proves the economics are reachable; closures are clearing the runway and Gregory will compound it." The evidence disagrees: after the largest single-year closure programme in DMP history, H1 FY26 underlying EBIT grew +1.0% — not the +10-15% operating leverage that would signal real margin recovery. DOM's 16.2% is national-share-led in two mature markets; JUBLFOOD's 20.0% is emerging-market growth-led. DMP carries developed-Asia mass-market exposure, sub-scale European commissaries across five countries, and chronic France underperformance — none of which Gregory's McDonald's CV directly addresses. If we are right, the consensus mean has to migrate to a 9-10x multiple on $157-171M EBITDA, anchoring the stock in the low-$11s — and Citi's $14.15 Sell, not the $15.68 Buy cluster, becomes the reference target. The cleanest disconfirming signal is H1 FY27 underlying op margin >9% with positive ANZ + Europe SSS prints.

Disagreement 3 — MFA performance-hurdle risk is the unpriced left tail. A consensus analyst would say: "DPZ-DPE has been a 20-year partnership; DPE is 24% of DPZ's international footprint; switching costs are bilateral and prohibitive." The evidence disagrees: DPZ's Q4 2025 call was the first time the parent publicly differentiated DPE from "other international operations as aligned with expectations" — language that historically precedes performance-hurdle invocation in master-franchise systems. If DPZ Q2 or Q3 2026 transcripts harden (specific phrases: "performance hurdle," "remediation," "territory review," "in-country support" reframed from partnership to oversight), the consensus framing of an unconditional MFA breaks and the entire valuation stack repriices on a 9-10x multiple. The cleanest disconfirming signal is DPZ moving DPE off the laggard list in either July or October 2026 commentary, especially with explicit "encouraged by Gregory" framing.

Evidence That Changes the Odds

How This Gets Resolved

The cleanest property of this setup is that the resolution clock is short. Four of seven signals print inside the next nine months (FY26 result Aug 26, DPZ Q2 late July, DPZ Q3 late October, AGM Nov 11), and two of the remaining three (H1 FY27, goodwill testing) resolve in the following six months. Only the Cowin pattern and Echo Law procedural docket are open-ended. A PM who builds a view against the $15.68 cluster does not have to hold a long-duration thesis to test the variant — the August 2026 print alone tests two of the three disagreements simultaneously, and the late-July DPZ Q2 commentary tests the third.

What Would Make Us Wrong

The most professional way to be wrong here is to read H1 FY26 +160bps margin expansion as closure mix when it is genuinely the start of a multi-half operating-leverage move. The H1 print is one data point. If the closure programme genuinely re-fitted the network — fewer stores, higher franchisee EBITDA, ANZ-style economics propagating into Europe — H2 op margin holds ≥8%, ANZ + Europe SSS turn positive, FY26 significant items collapse below $14M, and Gregory enters a network that has already done the hard work. In that world, Disagreements #1 and #2 both collapse, the consensus mean $15.68 starts to look conservative, and the right framing is "Citi was the wrong outlier, not the $15.68 cluster." The first concrete signal that this is happening is the August 2026 result printing FY26 underlying op margin ≥8% with ANZ SSS positive — at which point we should be downgrading the variant view, not defending it.

We could also be wrong on Disagreement #3 in a specific direction: DPZ Q4 2025 Weiner framing may be more about deflecting DPZ-level investor pressure (DPZ shares fell 13.6% on the international guidance suspension in 2024 and another 11% on the Q1 2026 SSS miss) than DPE-specific dissatisfaction. Weiner has incentive to single-name a culprit even if the partnership economics are intact. If DPZ Q2 2026 transcript moves DPE off the laggard list and reaffirms the 800-store FY26 international growth target with DPE explicitly in the mix, the MFA-hurdle variant compresses fast. The fragility here is that we read counterparty venting as institutional precursor language — easy to do, sometimes wrong.

Third, we could underestimate Gregory specifically. The McDonald's SVP Global Franchising chair is the highest-pedigree operator DMP has ever hired, and DPZ CEO Russell Weiner publicly endorsed the hire on the Q4 2025 call. Gregory has not yet had the chance to set out his framework — quantified margin targets at the August 2026 result, a strategy day inside H1 FY27, visible DPZ in-country engagement — and if he delivers on all three, the structural-margin-gap variant migrates from "structural mix is permanent" to "execution catalyst is finally present." That is not a defeat of the variant view today, but it is the path that converts it.

Finally, we could be wrong on time horizon. Even if our three disagreements are right in substance, a 12-18 month holding period may not be the window in which they price. The Bain Capital takeover rumour in October 2025 demonstrated that private-capital interest can short-circuit the deleveraging-path debate; a real bid in the $17.82-19.96 range would skip every fundamental resolution signal in the table above and force the variant to be defended at a settled price. The right answer is to hold a balanced view of the catalysts and not anchor entirely to "the FY26 result will resolve it."

The first thing to watch is the DPZ Q2 2026 earnings call in the week of 20-27 July 2026 — the only fundamental data point inside the next 90 days, and the single best leading indicator of whether the MFA performance-hurdle variant (the highest-impact disagreement in the ledger) is becoming the operative frame or the abandoned one.